VIVEbiotech participa en el proyecto europeo MAGIC
El consorcio MAGIC pretende
tener un impacto significativo en la vida de personas afectadas por distrofias musculares.
VIVEbiotech participa en el proyecto europeo MAGIC
CRISPR-Cas:From biology to therapeutic
Global Awards for Research in DMD-AWARD
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network
WADA invites applications for research projects on the development of gene doping detection methods
Nuestras cifras y logros del 2022
FDA approval of the world’s first gene therapy for Haemophilia
SETGYC 2022 Oral and Poster Award Winners
Outreach opportunity as a translator for EuroGCT
In memory of Dr. Manfred Schmidt
SETGYC Navidad 2021 | El mejor regalo
In memoriam Juan Carlos Ramirez
Educational Resource: New Horizons in the Management of ADA-SCID
Academia developing medicines for rare diseases to receive free EMA scientific advice
VIVEbiotech collaborates with Xyphos Biosciences for clinical development support...